Charles Schwab Corporation (SCHW)
NYSEFinancialsCapital MarketsSnapshot 2026-07-07
$101.92+1.29%
Close 2026-07-07 · 1-day change
Reading SCHW? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track SCHW free→NYSEFinancialsCapital MarketsSnapshot 2026-07-07
Reading SCHW? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track SCHW free→QuarterlyIQ Insights · SCHW
Price, fair value, and the multiples that frame it on the same time axis. Scroll over the price chart to zoom.
Daily closes. Earnings/event dots inline.
A consensus fair price across 14 valuation methods, at three horizons. Current price $101.92. As of 2026-07-08. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A long-thesis check that carries the widest uncertainty of the three horizons.
Above average on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $102 SCHW trades at 19× p/e, below its 24× p/e peer median, but our blended $92 fair value sits below the price. We hold it with medium confidence: our number sits below the analyst range and quality doesn't explain valuation multiples in this sub-industry, so the peer comparison is a weak guide. Analysts target $108–$137. Note: our $92 fair value sits below the entire analyst range ($108–$137). Not investment advice.
$108.00 – $137.00 (median $127.00) · 7 analysts · as of 2026-05-15
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
No fragility gates fired. Regime (Mania) does not concentrate fragility.
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
Looks cheaper than most peers in the same business.
Around its own typical valuation.
Trailing four: 2025-Q1, 2025-Q2, 2025-Q3, 2026-Q1
Score 100 = cheapest in the cohort, 0 = richest. Bars are filled left-to-right based on the peer-relative score (or PEG/self-history where shown).
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Each method's implied share price per horizon. Provisional rows use a projected (historical-CAGR) growth input rather than analyst or management guidance.
| Method | Horizon | Est. price | Multiple | Per-share input | EPS source | Confidence |
|---|---|---|---|---|---|---|
| analyst target | 12M | $127.00 | — | — | Analyst | high |
| dcf fcfe | 12M | $109.00 | — | — | Hist. CAGR | high |
| dcf fcff | 12M | $129.92 | — | — | Hist. CAGR | high |
| ddm gordon | 12M | $18.34 | — | — | TTM | high |
| graham number | 12M | $57.72 | — | — | TTM | high |
| Mgmt guidance | 12M | $78.11 | 24.0 | 3.25 | Mgmt | high |
| Peer P/B | 12M | $73.45 | 2.6 | 28.10 | TTM | high |
| Peer P/FCF | 12M | $81.86 | 14.8 | 5.55 | TTM | high |
| Peer P/E | 12M | $126.66 | 24.0 | 5.27 | TTM | high |
| Peer P/S | 12M | $42.51 | 3.0 | 14.16 | TTM | high |
| PEG | 12M | $156.54 | 29.7 | 5.27 | TTM | high |
| residual income | 12M | $38.84 | — | — | TTM | high |
| Own P/E history | 12M | $99.78 | 18.9 | 5.27 | TTM | high |
| triangulated | 12M | $127.86 | 24.0 | 5.32 | Triangulated | high |
| Mgmt guidance | 3Y | $151.58 | 24.0 | 6.31 | Mgmt(prov.) | medium |
| Peer P/B | 3Y | $99.49 | 2.6 | 38.07 | Hist. CAGR(prov.) | medium |
| Peer P/FCF | 3Y | $100.16 | 14.8 | 6.79 | Hist. CAGR(prov.) | medium |
| Peer P/E | 3Y | $213.16 | 24.0 | 8.87 | Analyst | medium |
| Peer P/S | 3Y | $61.76 | 3.0 | 20.57 | Analyst | medium |
| PEG | 3Y | $263.44 | 29.7 | 8.87 | Analyst | medium |
| Own P/E history | 3Y | $167.91 | 18.9 | 8.87 | Analyst | medium |
| Mgmt guidance | 5Y | $235.82 | 24.0 | 9.81 | Mgmt(prov.) | high |
| Peer P/B | 5Y | $121.79 | 2.6 | 46.60 | Hist. CAGR(prov.) | high |
| Peer P/FCF | 5Y | $114.57 | 14.8 | 7.77 | Hist. CAGR(prov.) | high |
| Peer P/E | 5Y | $272.00 | 24.0 | 11.32 | Analyst | high |
| Peer P/S | 5Y | $78.81 | 3.0 | 26.25 | Analyst | high |
| PEG | 5Y | $336.15 | 29.7 | 11.32 | Analyst | high |
| Own P/E history | 5Y | $214.26 | 18.9 | 11.32 | Analyst | high |
A “consensus-then vs. actual-now” overlay is on the way — what our valuation estimate said on a past date versus where the price actually landed.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.